My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    Lost in translation? Estrogen receptor status and endocrine responsiveness in breast cancer.

    Harbeck N, Rody A.

    J Clin Oncol. 2012 Mar 1;30(7):686-9. Epub 2012 Jan 30. No abstract available.

    PMID:
    22291083
    [PubMed - in process]

    Related citations

    2.

    Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.

    Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M.

    J Clin Oncol. 2012 Mar 1;30(7):722-8. Epub 2012 Jan 23.

    PMID:
    22271481
    [PubMed - in process]

    Related citations

    3.

    Deep time: the long and the short of adjuvant endocrine therapy for breast cancer.

    Burstein HJ, Griggs JJ.

    J Clin Oncol. 2012 Mar 1;30(7):684-6. Epub 2012 Jan 23. No abstract available.

    PMID:
    22271478
    [PubMed - in process]

    Related citations

    4.

    Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.

    Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK.

    J Clin Oncol. 2012 Feb 20;30(6):600-7. Epub 2012 Jan 17.

    PMID:
    22253459
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer.

    Munster PN, Moore AP, Ismail-Khan R, Cox CE, Lacevic M, Gross-King M, Xu P, Carter WB, Minton SE.

    J Clin Oncol. 2012 Feb 10;30(5):533-8. Epub 2012 Jan 9.

    PMID:
    22231041
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Dose intensification in hormone receptor-negative and/or human epidermal growth factor receptor 2-negative high-risk primary breast cancer.

    De Giorgi U, Amadori D.

    J Clin Oncol. 2012 Mar 1;30(7):758; author reply 759-60. Epub 2011 Dec 27. No abstract available.

    PMID:
    22203774
    [PubMed - in process]

    Related citations

    7.

    Distribution of coronary artery stenosis after radiation for breast cancer.

    Nilsson G, Holmberg L, Garmo H, Duvernoy O, Sjögren I, Lagerqvist B, Blomqvist C.

    J Clin Oncol. 2012 Feb 1;30(4):380-6. Epub 2011 Dec 27.

    PMID:
    22203772
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    High-dose chemotherapy as adjuvant therapy in breast cancer: could there be a survival benefit?

    Moroni M.

    J Clin Oncol. 2012 Mar 1;30(7):759; author reply 759-60. Epub 2011 Dec 27. No abstract available.

    PMID:
    22203770
    [PubMed - in process]

    Related citations

    9.

    Zirconium-89-trastuzumab positron emission tomography as a tool to solve a clinical dilemma in a patient with breast cancer.

    Gaykema SB, Brouwers AH, Hovenga S, Lub-de Hooge MN, de Vries EG, Schröder CP.

    J Clin Oncol. 2012 Feb 20;30(6):e74-5. Epub 2011 Dec 27. No abstract available.

    PMID:
    22203768
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Breast cancer radiotherapy and coronary artery stenosis: location, location, location.

    Zagar TM, Marks LB.

    J Clin Oncol. 2012 Feb 1;30(4):350-2. Epub 2011 Dec 27. No abstract available.

    PMID:
    22203762
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Breast cancer survivors' perceptions of survivorship care options.

    Mayer EL, Gropper AB, Neville BA, Partridge AH, Cameron DB, Winer EP, Earle CC.

    J Clin Oncol. 2012 Jan 10;30(2):158-63. Epub 2011 Dec 12.

    PMID:
    22162585
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

    Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, Feroce I, Pizzamiglio M, Sandri MT, Gulisano M, Bonanni B, Decensi A.

    J Clin Oncol. 2012 Jan 10;30(2):151-7. Epub 2011 Dec 12.

    PMID:
    22162577
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

    Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Taylor SK, Hood N.

    J Clin Oncol. 2012 Jan 10;30(2):164-71. Epub 2011 Dec 12.

    PMID:
    22162568
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    Obesity and breast cancer outcome: adding to the evidence.

    Chlebowski RT.

    J Clin Oncol. 2012 Jan 10;30(2):126-8. Epub 2011 Dec 12. No abstract available.

    PMID:
    22162565
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.

    Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA.

    J Clin Oncol. 2012 Jan 1;30(1):19-26. Epub 2011 Dec 5.

    PMID:
    22147742
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Should all women with breast cancer be tested for BRCA mutations at the time of diagnosis?

    Narod SA.

    J Clin Oncol. 2012 Jan 1;30(1):2-3. Epub 2011 Dec 5. No abstract available.

    PMID:
    22147741
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Role of nonclinical factors in the receipt of high-quality systemic adjuvant breast cancer treatment.

    Griggs JJ.

    J Clin Oncol. 2012 Jan 10;30(2):121-4. Epub 2011 Dec 5. No abstract available.

    PMID:
    22147739
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    CYP2D6 and tamoxifen: awaiting the denouement.

    Brauch HB, Schroth W, Ingle JN, Goetz MP.

    J Clin Oncol. 2011 Dec 1;29(34):4589-90; author reply 4590-1. Epub 2011 Oct 31. No abstract available.

    PMID:
    22042960
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Do women remain at risk even if they do not inherit a familial BRCA1/2 mutation?

    Robson M.

    J Clin Oncol. 2011 Dec 1;29(34):4477-8. Epub 2011 Oct 31. No abstract available.

    PMID:
    22042956
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.

    Haffty BG, Hunt KK, Harris JR, Buchholz TA.

    J Clin Oncol. 2011 Dec 1;29(34):4479-81. Epub 2011 Oct 31. No abstract available.

    PMID:
    22042942
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk